Development and validation of a stability indicating HPLC assay method for cyclosporine in cyclosporine oral solution USP.
The suitability of the United States Pharmacopeia (USP) assay method for analysing stressed samples of cyclosporine oral solution USP was evaluated for stability samples by analyzing cyclosporine oral solution after acid, alkali, hydrogen peroxide, heat and light treatment. Some of the degradants generated during stress testing, as well as dihydrocyclosporine A, which is a known degradant of cyclosporine A, were not adequately resolved from the cyclosporine peak and mobile phase adjustments did not improve the resolution. In addition, isocyclosporine A, another known degradant of cyclosporine, could not be quantitated as it was eluting too early with the system peaks. Therefore, a binary gradient, reverse phase, stability indicating, HPLC method for the assay of cyclosporine in cyclosporine oral solution USP has been developed and validated. Analysis of degraded samples showed that the cyclosporine A eluted as a spectrally pure peak resolved from its degradation products.
Analytical Research&Development, Panacea Biotec Ltd., Chandigarh Road, PO Lalru (140 501), Punjab, India.
M
M
Kumar
S K
SK
Singhal
A
A
Singh
D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D016572:Cyclosporine / Q000032:analysis*; D011786:Quality Control; D015203:Reproducibility of Results; D012996:Solutions
D018501:Antirheumatic Agents; D012996:Solutions; D016572:Cyclosporine